| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e5e37c55ff492dd0f59ba7e84e2346c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F8-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G85-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F8-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G85-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785 |
| filingDate |
1979-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c551cea72856e6faab489a2f512e6e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b005bc74965ae5f058964a3da71ad0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87f17b23320730112a625cb88b2c91f5 |
| publicationDate |
1980-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0013000-A2 |
| titleOfInvention |
Polymeric agent for releasing 5-aminosalicylic acid or its derivatives into the gastrointestinal tract, pharmaceutical formulation comprising said agent,method of its preparation and method of preparing said formulation |
| abstract |
An intestinal anti-inflammatory preparation comprising a polymeric agent for releasing 5-aminosalicylic acid or its salts is disclosed. The polymeric agent comprises a nonabsorbable pharmacologically acceptable organic polymer backbone containing aromatic rings to which are covalently bonded via azo bonds a plurality of salicylic acid or salicylate's salt groups. The azo bonds attach to the salicylates' 5-position carbon. The polymers' azo bonds undergo bacterial cleavage in the mammalian lower bowel to release 5-aminosalicylic acid and/or its salts. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6509441-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0123485-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9948932-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9948932-A3 |
| priorityDate |
1978-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |